Evidence map›Paper›PMID 28973554›Full record

ReviewNeurosurgery2018

Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol.

Joao Prola Netto, Jeffrey Iliff, Danica Stanimirovic, Kenneth A Krohn, Bronwyn Hamilton, Csanad Varallyay, Seymur Gahramanov, Heike Daldrup-Link, Christopher d'Esterre, Berislav Zlokovic and 9 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Neurosurgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. CD36 - A novel molecular target in the neurovascular unit.The European journal of neuroscience · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2019
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 2 countries.

Joao Prola NettoDepartment of Neurology, Oregon Health & Science University, Portland, Oregon.
Jeffrey IliffDepartment of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon.
Danica StanimirovicHuman Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada.
Kenneth A KrohnDepartment of Radiology, University of Washington, Seattle, Washington.
Bronwyn HamiltonDepartment of Neuroradiology, Oregon Health & Science University, Portland, Oregon.
Csanad VarallyayDepartment of Neurology, Oregon Health & Science University, Portland, Oregon.
Seymur GahramanovDepartment of Neurosurgery, University of New Mexico, Albuquerque, New Mexico.
Heike Daldrup-LinkDepartment of Radiology, Stanford University, Stanford, California.
Christopher d'EsterreDepartment of Radiology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada.
Berislav ZlokovicZikha Neurogenetic Institute, University of Southern California, Los Angeles, California.
Haris SairDepartment of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland.
Yueh LeeDepartment of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Saeid TaheriDepartment of Radiology and Radiological Sciences, Medical University of South Carolina, Charleston, South Carolina.
Rajan JainDepartment of Radiology and Neurosurgery, New York University School of Medicine, New York, New York.
Ashok PanigrahyDepartment of Radiology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
Daniel S ReichTranslational Neuroradiology Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Lester R DrewesDepartment of Biomedical Sciences, University of Minnesota, Duluth, Minnesota.
Mauricio CastilloDepartment of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Edward A NeuweltDepartment of Neurology, Oregon Health & Science University, Portland, Oregon.
Oregon Health & Science University · USUniversity of North Carolina at Chapel Hill · USChildren's Hospital of Pittsburgh · USJohns Hopkins University · USMedical University of South Carolina · USNational Institute of Neurological Disorders and Stroke · USNational Research Council Canada · CANew York University · USStanford University · USUniversity of Calgary · CAUniversity of Minnesota, Duluth · USUniversity of New Mexico · USUniversity of Southern California · USUniversity of Washington · US

Funding

Multimodal MRI in Multiple SclerosisZIANS003119 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI REICH, DANIEL · 2010 to 2025
$53.4M
Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's DiseaseP01AG052350 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Daniel A Nation, ARTHUR W TOGA · 2016 to 2026
$28.4M
NIA NIH HHS P01 AG052350
6 · The paper itself

Abstract

Physiological and pathological processes that increase or decrease the central nervous system's need for nutrients and oxygen via changes in local blood supply act primarily at the level of the neurovascular unit (NVU). The NVU consists of endothelial cells, associated blood-brain barrier tight junctions, basal lamina, pericytes, and parenchymal cells, including astrocytes, neurons, and interneurons. Knowledge of the NVU is essential for interpretation of central nervous system physiology and pathology as revealed by conventional and advanced imaging techniques. This article reviews current strategies for interrogating the NVU, focusing on vascular permeability, blood volume, and functional imaging, as assessed by ferumoxytol an iron oxide nanoparticle.

Indexed as

Contrast MediaFerrosoferric OxideMetal NanoparticlesAnimalsBlood-Brain BarrierHumansNeuroimagingContrast MediaFerrosoferric Oxide

Identifiers

PMID28973554
PMCPMC6256943
OpenAlexW2736668400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.